Sign in
Taking peopleNo phase

INTERACT4 Expansion - Validation Study

Key facts

Who runs it
The George Institute
Where
Australia6 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
163 people, planned
Started
18 Sept 2026
Expected to end
1 Jun 2027
Type of study
Observational
Treatments tested
  • LVOne
Record updated
26 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Adults (age ≥18 years)
  • Acute syndrome that is due to presumed acute stroke, defined as FAST (Face, Arm, Speech, Time) scores of ≥2 with an arm motor deficit
  • Time ≤3 hours from last seen well
  • Systolic BP (SBP) ≥150mmHg

Who cannot take part

  • Severe known co-morbid disease (e.g. cancer, chronic airflow disease, severe dementia, severe heart failure, pre-existing disability [needing help])
  • Known history of epilepsy or seizure at onset
  • Recent head injury (where there is potential for another type of intracranial haemorrhage or head trauma)
  • Hypoglycaemia (glucose<4.0 mmol/L) as measured in the ambulance
  • Participants in coma (no response to tactile/verbal stimulation); or/and do not respond to "P" or "U" on the alert/verbal/painful/unresponsive (APVU) responsiveness scale

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

As an investigator-initiated and conducted, multi-centre, open-label, single-arm prospective observational trial, INTERACT4 Expansion aims to evaluate the feasibility of setting up and conducting a trial that uses a point-of-care GFAP test to identify ICH in patients presenting with acute stroke-like symptoms in the pre-hospital setting.

Treatments tested

  • LVOne

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
INTEnsive Ambulance-delivered Blood Pressure Reduction in Biomarker-identified Hyper-ACute Intracerebral Haemorrhage Trial - Validation Study
Record updated
26 October 2026